Dr. Reddy’s shares hit record high! Pharma stock up 5% in 3 sessions
Shares of Dr. Reddy's Laboratories have risen 36% against its 52-week low of ₹5,212.10 touched on October 30, 2023.
pharma stock
August 2024
March 2024
January 2024
December 2023
September 2023
August 2023
July 2023
May 2023
Aurobindo Pharma shares rise 2% on USFDA nod for nasal spray
The pharma company has received approval to manufacture and market Mometasone Furoate Monohydrate Nasal Spray 50 mcg, which will be launched in Q1 FY25.
Cipla shares surge 7% post Q3; hit fresh all-time high
The share price of Cipla touched a new record high of ₹1,408.55, while market capitalisation climbed to ₹1.12 lakh crore.
Biocon shares rise 2% on deal with Sandoz
Biocon Biologics, a subsidiary of Biocon, has signed a distribution agreement with Sandoz for an immunity-linked injection in Japan.
From ₹397 to ₹1,081: This largecap pharma stock surges 170% in 10 months
The homegrown pharma company has outperformed the BSE Sensex and Healthcare index in terms of returns in the last one year.
Mankind Pharma shares skid 4% amid block deal buzz
Three private equity funds, namely Chrys Capital, Capital Group, and Everbridge Partners, were reportedly looking to sell stakes worth $592 million in Mankind Pharma via the block deal.
Cipla shares rise 2% on deal to acquire South Africa’s Actor Pharma
Cipla South Africa has signed a binding term sheet with Actor Holdings to acquire 100% of the issued ordinary shares of Actor Pharma.
This largecap pharma stock surges 32% in two days; here’s why
In the past one month, the share price has gained nearly 57%, while it more than doubled against its 52-week low of ₹861.5 touched on May 22, 2023.
Ajanta Pharma hits all-time high on strong Q1; surges 55% in 9 months
The pharma company has declared its first interim dividend of ₹315 crore for FY24, which translates into ₹25 per share, or 1,250%, for each ₹2 face value share.
This pharma stock surges 10% post 33% fall in two sessions
The stock has fallen nearly 27% since May 18, 2023, after the pharma company released its fourth-quarter results
